Encompass Health Corporation (NYSE:EHC) Shares Sold by Cerity Partners LLC

Cerity Partners LLC lowered its stake in shares of Encompass Health Corporation (NYSE:EHC) by 19.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,727 shares of the company’s stock after selling 1,110 shares during the period. Cerity Partners LLC’s holdings in Encompass Health were worth $479,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. OneDigital Investment Advisors LLC acquired a new position in Encompass Health during the first quarter worth $263,000. GAMMA Investing LLC boosted its stake in Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock worth $240,000 after buying an additional 419 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in Encompass Health by 30.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock worth $972,000 after buying an additional 2,218 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock worth $276,000 after buying an additional 172 shares during the last quarter. Finally, Fifth Third Bancorp boosted its stake in Encompass Health by 88.7% during the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company’s stock worth $434,000 after buying an additional 2,017 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC stock opened at $107.53 on Friday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $10.84 billion, a PE ratio of 22.22, a P/E/G ratio of 2.17 and a beta of 0.88. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13. The business’s fifty day moving average price is $117.99 and its 200 day moving average price is $107.40.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.12 EPS. On average, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.71%. Encompass Health’s dividend payout ratio is 15.70%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. UBS Group lifted their target price on Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Truist Financial restated a “buy” rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Stephens upgraded Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 target price on the stock in a research report on Thursday, June 5th. Royal Bank Of Canada lifted their target price on Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research report on Monday, April 28th. Finally, Wall Street Zen downgraded Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $131.50.

Insiders Place Their Bets

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the company’s stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the sale, the insider directly owned 11,958 shares of the company’s stock, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the company’s stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the sale, the executive vice president directly owned 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 in the last quarter. 2.00% of the stock is owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.